Sekisui Diagnostics Company Profile

05:20 EDT 24th April 2017 | BioPortfolio

A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices throughout the world. Formerly known as Genzyme Diagnostics, Sekisui Diagnostics has over 30 years of experience developing, manufacturing and commercializing a variety of unique products which meet the needs of the global diagnostics market. Learn more about Sekisui Diagnostics at

News Articles [785 Associated News Articles listed on BioPortfolio]

Sekisui Diagnostics launches bacterial vaginosis rapid test in Europe, Middle East and North Africa

Global diagnostics firm Sekisui Diagnostics has introduced OSOM BVBLUE test in Europe, Middle East and North Africa.

Sekisui Diagnostics Announces Launch of OSOM® BVBLUE® Rapid Test for Bacterial Vaginosis in Europe, Middle East and North Africa

LEXINGTON, Mass., Jan. 11, 2017 /PRNewswire/ -- Today, Sekisui Diagnostics announces the launch of the OSOM® BVBLUE® Test in Europe, Middle East and North Africa.  The OSOM® BVBLUE® Test, whi...

US FDA asks Sekisui how it will fix API test data problems at Japan plant

The US FDA has asked Sekisui Medical to specify how it will resolve data integrity issues uncovered during an inspection of its API plant in Hachimantai, Japan in June.

Sekisui XenoTech adds new test systems to service offerings

Sekisui XenoTech has added new dermal subcellular fraction test systems to its contract research services.

Sekisui Medical Co., Ltd. Product Pipeline Analysis, 2016 Update Prices from USD $750

SummarySekisui Medical Co., Ltd. Sekisui Medical, a subsidiary of Sekisui Diagnostics, LLC. is a medical company that develops, produces, and distributes diagnostic reagents, medical devices, pharmace...

Sekisui XenoTech Adds New Dermal Subcellular Fraction Test Systems

  Life Sciences Jobs   ...

Global Influenza Diagnostics Market 20172021 [Updated: 13032017] Prices from USD $3500

About Influenza DiagnosticsThe global influenza diagnostics market is expected to grow at a moderate pace in the forecast period. The factors that are expected to drive the market in the forecast peri...

The Top 100 Manufacturers Of IVD Reagents, Instruments & Accessories Worldwide

LONDON, Jan. 16, 2017 /PRNewswire/ -- Did you know?- Transasia Bio-Medicals is India's largest in-vitro diagnostic company.- Nova Biomedical is the largest privately owned in-vitro diagnostic company ...

Drugs and Medications [20 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [A.M. Home Diagnostics Inc. dba Healthline]


Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

PubMed Articles [268 Associated PubMed Articles listed on BioPortfolio]

Progress and potential of RAS mutation detection for diagnostics and companion diagnostics.

The importance of RAS mutation in carcinogenesis is established, and knowledge of an individual cancer's mutation status is important for optimal treatment.

Exploring the Case for a Global Alliance for Medical Diagnostics Initiative.

In recent years, the private and public sectors have increased investments in medical diagnostics for low- and middle-income countries (LMICs). Despite these investments, numerous barriers prevent the...

Resistance diagnosis and the changing economics of antibiotic discovery.

Point-of-care diagnostics that can determine an infection's antibiotic sensitivity increase the profitability of new antibiotics that enjoy patent protection, even when such diagnostics reduce the qua...

Next-Generation Sequencing in Cancer Diagnostics.

This commentary highlights the article by Misyura et al that underscores the use of next-generation sequencing platforms for detection and verification of somatic variants.

Current position of diagnostics and surgical treatment for upper tract urothelial carcinoma.

The applicability of urinary biomarkers and optical diagnostics in upper urinary tract carcinoma (UUTUC) are increasingly debated. To receive insight in the opinion of the urological community involve...

Clinical Trials [134 Associated Clinical Trials listed on BioPortfolio]

Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobi...

HIV Point-of-Care Test Evaluation in Infants

HIV Point-of-Care tests in Babies Study (BABY) - Operational evaluation of HIV Point-of-Care tests for very early infant HIV diagnostics in infants born to HIV infected mothers in Mbeya, T...

Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test

This study has been designed to evaluate the performance of the Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 rapid test. The device is intended to qualitatively detect the presence of ...

Registry of Malignant Arrhythmias and Sudden Cardiac Death - Influence of Diagnostics and Interventions

The "Registry of Malignant Arrhythmias and Sudden Cardiac Death - Influence of Diagnostics and Interventions (RACE-IT)" represents a mono-centric registry of patients being hospitalized su...

Diagnostics and Therapy of Disease-Related Quality of Life of Patients With Breast Cancer

Quality of Life-Diagnostics and -Therapy in Individual Patients with Breast Cancer. A randomized study including 200 patients, 5 clinics and 43 general practitioners as coordinating docto...

Companies [875 Associated Companies listed on BioPortfolio]

Sekisui Diagnostics

A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices ...

Innotrac Diagnostics Oy

Founded 1995Located in Turku, FinlandInnotrac Diagnostics provides health care professionals with a comprehensive immunoassay platform and test portfolio for rapid and high quality results in cardiac ...

Critical Diagnostics Critical Diagnostics

Critical Diagnostics ( develops novel biomarkers to help physicians optimize patient care in cardiovascular diseases, while containing healthcare costs...

ERBA Diagnostics Inc.

ERBA Diagnostics, Inc. (, headquartered in Miami Lakes, Florida, is a fully integrated in vitro diagnostics company that develops, manufactures and distrib...

JFK Communications, Inc.

Fujirebio Diagnostics is the premier cancer diagnostics company and the industry leader in cancer biomarker assays. Fujirebio Diagnostics specializes in the clinical development, manufacturing and co...

More Information about "Sekisui Diagnostics" on BioPortfolio

We have published hundreds of Sekisui Diagnostics news stories on BioPortfolio along with dozens of Sekisui Diagnostics Clinical Trials and PubMed Articles about Sekisui Diagnostics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sekisui Diagnostics Companies in our database. You can also find out about relevant Sekisui Diagnostics Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks

Searches Linking to this Company Record